BridgeBio Pharma, Inc. Common Stock (BBIO) Financials
Key financial figures for BridgeBio Pharma, Inc. Common Stock (Q1 2026).
- Revenue
- $195M
- Net Income
- -$167M
- EPS
- $-0.84
- Total Assets
- $1.4B
- Operating Cash Flow
- -$197M
Full income statement, balance sheet, and cash flow for BridgeBio Pharma, Inc. Common Stock on SentiSense.